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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S110inadequate barium perfusion. Future studies of cartilage canals using
SWI are likely to improve our understanding of the pathogenesis and
progression of OC and other developmental orthopedic diseases by
providing a non-invasive method to evaluate the vascular supply and
associated pathology of the AECC.
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VERIFICATION OF THREE DIFFERENT MMP-13 ISOFORMS
EXPRESSION IN HUMAN OSTEOARTHRITIC CARTILAGE
A. Farran y, L. Tío y, J. Monfort y, J.-P. Pelletier z, J. Martel-Pelletier x.
y IMIM-Hosp. del Mar, Barcelona, Spain; zCtr. Hosp.ier de l'Université de
Montréal, Montreal, Montreal, QC, Canada; xDept. of Pharmacology, Dept.
of Med., Montreal, QC, Canada
Purpose: Collagenase-3 (MMP-13) is a human matrix metal-
loproteinase highly overexpressed in diseases where tissue repair and
remodelling is needed, such as rheumatoid arthritis (RA), osteoarthritis
(OA) and some cancers. However, its expression in normal tissues is
limited to fetal ossiﬁcation processes. MMP-13 can digest ﬁbrillar
collagen, preferentially type II collagen, but also glomerular collagens
and other components of the extracellular matrix (ECM). MMP-13
structures is composed of 4 domains: a hydrophobic pre-domine
necessary for the secretion, a pro-domain involved in enzyme latency,
a catalytic domain, and a hemopexin-like domain This last is essential
for the substrate recognition and collagenolytic activity.
Three different MMP-13 transcripts of 3.0, 2.5 and 2.2/2.0 kb have been
described to be expressed in human cells. The 2.5kb transcript (isoform
205) corresponds to the MMP-13 original form, while the 3.0kb tran-
script (isoform 344) presents an insertion at the C-terminal produced
by lack of exon 9B splicing. Finally, the smaller transcript of 2.2/2.0kb
(isoform 209) presents a deletion (probably due to alternative splicing)
of 88 amino acids, also affecting the C-terminal domain. Our objective is
to demonstrate the presence of these three MMP13 protein isoforms in
human OA samples.
Methods: A speciﬁc peptide from each isoform was synthesized and
two rabbits were immunized with each peptide. The antibodies
recognizing each isoform were puriﬁed from the total antiserum by
sulfolink column. On the other hand MMP-13 isoforms were synthe-
tized in vitro in a Sf9 insect cells system, with a recombinant baculo-
virus containing MMP-13 transcripts cloned. The insect cells were
culture to produce the respective isoforms, and they were puriﬁed by
molecular exclusion chromatography. These proteins were used to test
the speciﬁcity of the polyclonal antibodies obtained by Western Blot.
Finally, ECM proteins were extracted from cartilage samples obtained
from knee and hip arthrosic patients undergoing arthroplasty, using
Guanidinium chloride (4M) method. The presence of the 3 isoforms in
these samples was assay by western blot with the speciﬁc isoform
polyclonal antibodies obtained.
Results: The puriﬁed polyclonal antibodies show immunoreactivity
only in front of its speciﬁc isoform, showing that they are useful for the
detection of each speciﬁc isoform in the samples. In all the samples
tested, different intensities of the bands corresponding of each antibody
were detected. No relative quantiﬁcation could be performed due to the
lack of a standard of each MMP-13 isoforms that allows us to compare
the afﬁnity of each polyclonal antibody to each speciﬁc isoform.
Conclusions: The MMP-13 mRNA isoforms are translated to protein in
cartilage OA samples. The transcripts containing the deleted and the
alternatively spliced exons differ from the original sequence in the
region coding for the hemopexin-like domain. This domain is necessary
to cleave native triple helical collagens and provide to the protease its
substrate speciﬁcity and afﬁnity. The expression of 209 and 344 isoform
could have clinical implications in OA if they present different sub-
tracted recognition and/or speed of degradation, explaining some
differences observed in the pathophysiology of the disease.
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QUANTITATIVE ECHOGENICITY OF SMALL INTRA-ARTICULAR
DEPOSITS OF CALCIUM, HYALINE CARTILAGE THICKNESS AND
SONOGRAPHIC ASPECTS OF THE SYNOVIUM IN PATIENTS WITHOUT
RADIOGRAPHIC CHONDROCALCINOSIS
A. Checa y, H. Hussain y, E. Russell z. yDrexel Univ. Coll. of Med.,
Philadelphia, PA, USA; zChristiana Care Hlth.System, Newark, DE, USA
Purpose: Ultrasonography is very helpful in the detection of intra-
articular crystal deposits and also in distinguishing gout fromchondrocalcinosis (CC). However, only three patients without CC on
radiographies with evidence of calcium deposits within the cartilage
detected by ultrasound (US) have been reported.
Methods: In a cohort of 406 patients who underwent musculoskeletal
US from January 2010 to June 2011, 30 patients with chondrocalcinosis
were identiﬁed by the presence of calcium deposits using a machine
equipped with an 8-13 MHz linear transducer. The presence of chon-
drocalcinosis was sonographically recognized as hyperechoic foci
within the articular cartilage or ﬁbrocartilage. Once aggregates of
calcium were identiﬁed, the size was measured unless the deposit
burden was too large to quantify. The quantitative echogenicity was
assessed among all patients with chondrocalcinosis. A sampling of the
area of the calcium aggregates with apparent highest echogenicity was
matched with the gray scale bar and measured in a scale of 0 to 10
centimeters. In addition, cartilage thickness was measured on trans-
verse view obtained with the knee fully ﬂexed. In the same view,
a minimal-crystal distance of the deposit (distance of the superior
margin of the deposit to the cartilage surface) was calculated.
Results: We identiﬁed 30 patients with US evidence of aggregates of
calcium within the wrist or knee cartilage. Two patients were excluded
from the study since prior radiographs of the joint were not available. Of
the 28 patients included in the study, 9 (32%) showed radiographic
evidence of chondrocalcinosis and 19 (68%) patients had no evidence of
chondrocalcinosis on prior radiographs (p ¼ 0.001).Those patients with
sonographic, but not radiographic CC, predominately had small calcium
deposition [mean: 1.5mm (range: 0.8mm- 4.6mm)] vs. the group with
radiographic CC that showed extensive deposition (Panel A). The group
with radiographic CC showed deposits in more than one compartment
(82%), which was observed in only 33% in the group with no radio-
graphic CC. The patients with CC on x-ray had deposits with higher
echogenicity (mean: 6.2) compared with those without (mean: 5.7).
However, it was not statistically signiﬁcant (p¼0.16). Cartilage thickness
was not different between patients with or without radiographic CC
[mean: 1.96mm vs. 2.0mm respectively, p¼0.84]. Patients without
radiographic CC showed a small minimal-crystal distance [mean: 0.5
mm (range: 0-1.3mm)] compared with the group with CC on radiog-
raphies [mean: 0.8mm (range: 0.3-1.6)]. In the ﬁrst group (21 knees),
this distance was similar in presence or not of non-shadowing hyper-
echoic dots within the synovium or effusion [mean: 0.5mm vs. 0.4 mm,
p¼0.25]. Effusion and synovial hypertrophy were detected in the
majority of patients irrespective of the presence of small or extensive
deposits of calcium. Roughly one-third of all patients showed hyper-
echoic dots within the synovium. The presence of dots within the
effusion was detected in 42% in the group with occult CC vs. 33% with
radiographic CC (Panel B, C and D). Ultimately, a calciﬁed meniscus was
identiﬁed in 26% of patients without radiographic CC. Conversely, all
patients with radiographic evidence of CC showed a meniscocalcinosis
sonographically (Panel B).
Conclusions: Ultrasound was better than convectional radiography in
detecting small deposits of calcium within the cartilage. Knee cartilage
thickness was similar in both groups with and without radiographic CC.
We speculate that small size of the calcium deposits, mainly localized in
one compartment of the knee, lower echogenicity, and the low rate ofĂ
